www.SecuringIndustry.com Competitors

BioPharma Dive provides in-depth journalism and insight into the most impactful news and trends shaping the biotech and biopharmaceutical industry.

Kickstarting healthcare conversations. PharmaTimes Magazine is the leading pharmaceutical magazine for senior decision makers in the pharma and healthcare industries. It is recognised for its wide-ranging coverage of the key developments facing this fast-paced sector, and its analytical, independent content. PharmaTimes Magazine has a dedicated staff of writers and editors who have many years' experience in writing and editing copy for pharma and healthcare readers in national newspapers, magazines and online. PharmaTimes Magazine readers range from pharmaceutical executives, to healthcare professionals (chief pharmacists, medicines management, academic health science networks and NHS commissioners), to government ministers. Available in print and digital versions, on Newsstand and Google Play. PharmaTimes Competitions provide business partners and sponsors with unique access to senior decision makers, in order to gain real insight into the business challenges faced by pharma customers. This allows partners and sponsors the opportunity to build relationships and formulate service offerings around customer needs.

The Pharma Letter provides accurate, unbiased business information on the worldwide pharmaceutical, generic and biotechnology industries. Thousands of executives in these and allied organisations find The Pharma Letter a necessary read to keep them the first to know about current news and events, written whilst the news is fresh and has the greatest impact on commercial decisions. Save time and effort with authoritative, analysed and unbiased news delivered to you daily online straight to your screen, together with e-mail alerts and full access to The Pharma Letter's searchable archive from 1991. Coverage includes: * Company news — Financial reports, marketing developments, trends and strategies, corporate development, company profiles, legal influences, R&D trends, M&A activity, sales performance, stock market analyses and personnel appointments. * Product news — Drug submissions, approvals and rejections, licensing arrangements, clinical trial developments and results, product development and new product introductions. * European, USA and world news — Regulatory developments, FDA/EMEA news, market legislation, pharma market movements, reviews of current and proposed legislation and regulation, conference details and write-ups.